Vachelli et al. highlighted the importance of the presence of the protein Formyl Peptide Receptor-1 (FPR-1) on DCs in breast and colon cancer, as its absence leads to a decrease in overall survival due to a lack of anticancer immune response because of the failure of antigen presentation and hence the failure of T-cell activation [71]. The gene discussed is FPR1; the disease is malignant colon neoplasm.